Pyrazolopyrimidines as protein kinase inhibitors

Details for Australian Patent Application No. 2006299338 (hide)

Owner Schering Corporation

Inventors Guzi, Timothy J.; Dwyer, Michael P.; Paruch, Kamil; Alvarez, Carmen S.

Agent Griffith Hack

Pub. Number AU-A-2006299338

PCT Pub. Number WO2007/041712

Priority 60/724,197 06.10.05 US

Filing date 4 October 2006

Wipo publication date 12 April 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041712 Priority application(s): WO2007/041712

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299339-Production and purification of IL-29

2006299337-Embolic protection device